Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Intravenous Silibinin in Combination With Peg-interferon and Ribavirin in Nonresponders (NRSily)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT00684268
Recruitment Status : Completed
First Posted : May 26, 2008
Last Update Posted : March 27, 2017
Sponsor:
Information provided by (Responsible Party):
Peter Ferenci, Medical University of Vienna

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Completed
Actual Primary Completion Date : February 2011
Actual Study Completion Date : June 2011